Speaker Profile
PMWC PIONEER AWARD
Pioneered precision medicine at CDC, Merck, and FNIH
M.D., MPH, President and Chief Executive Officer, FNIH
Biography
Dr. Julie Louise Gerberding is the President and CEO of the Foundation for the National Institutes of Health (FNIH), a non-profit organization that builds public-private-patient biomedical research partnerships to address important medical challenges in support of the NIH mission. She also co-chairs the CSIS Bipartisan Alliance for Global Health Security. Dr. Gerberding formerly served as President of Merck Vaccines and as Executive Vice President and Chief Patient Officer at Merck Co., Inc. From 2003-2009, Dr. Gerberding led the U.S. Centers for Disease Control and Prevention (CDC). Her current board service includes HilleVax, Mayo Clinic, National Health Council, and Case Western Reserve University. Dr. Gerberding is a member of the National Academy of Medicine and the adjunct faculties of the University of California, San Francisco, and Case Western Reserve University.
Session Abstract – PMWC 2025 Silicon Valley
Track Chairs:
Charles Chiu, UCSF
- PMWC 2025 Award Ceremony
Pioneer Honoree: Julie Louise Gerberding, FNIH
- Keynote: From Crisis to Cure: Navigating Public Health Challenges in the Era of Precision Diagnostics
- Julie Louise Gerberding, FNIH
- Harnessing Emerging Diagnostic Technologies in Primary and Critical Care (PANEL)
Chair: Mylynda Massart, UPMC
- Christopher Woods, Duke
- Helen Chu, U of Washington
- Yvonne Maldonado, Stanford
- Rose Lee, NIH - New Viral and Microbiome Associations with Cancer
Chair: Charles Chiu, UCSF
- Nancy Joseph, UCSF
- Melody Smith, Stanford
- Metagenomics and Partnerships: Monitoring Infectious Disease Threats
- Duncan MacCannell
- Adi V. Gundlapalli, CDC
- Mindy Nye, LabCorp - Innovative Therapeutics and Host-Pathogen Interactions in Infectious Disease Management (PANEL)
- Victor Nizet, UCSD
- Brad Spellberg, LA General Medical Center
- Nevan Krogan, UCSF
- Margaret Riley, University of Massachusetts
